Immunomodulating effect of a traditional Japanese medicine, Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan), on Th1 predominance in autoimmune MRL/MP-lpr/lpr mice

被引:20
作者
Furuya, Y
Kawakita, T
Nomoto, K
机构
[1] Kanebo Ltd, Dept Pharmacol, Tradit Japanese Med, Osaka 5340016, Japan
[2] Kyushu Univ, Med Inst Bioregulat, Dept Immunol, Fukuoka 812, Japan
[3] Healthcare Res Labs, Osaka 5340016, Japan
关键词
IFN-gamma; IL-4; Hachimi-jio-gan;
D O I
10.1016/S1567-5769(00)00024-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan, HMG), a traditional Japanese herbal medicine, has been used for disorders accompanying aging. Oral administration of HMG; from 8 to 16 weeks of age to MRL/lpr mice as a lupus-like autoimmune model ameliorated significantly some nephritis parameters, proteinuria and immune complex deposition in the kidney. Further, HMG reduced significantly the degree of lymphadenopathy and the serum level of immunoglobulin (Ig) G2a anti-dsDNA specific auto-antibody, even at 12 weeks of age. Simultaneously, interferon (IFN)-gamma production from anti-CD3 stimulated B220(-) T cells was suppressed by HMG. whereas interleukin (IL)-3 production was promoted. Examination of cytokine mRNA expressions in CD4 positive cells showed clearly that T cell differentiation was shifted from T helper (Th)1 to Th2 predominance by HMG. Furthermore, we demonstrated that HMG suppressed IL-12 mRNA expression in spleen cells which is a marker of Th1 predominance in MRL/lpr mice. These results suggested that HMG modulated an imbalance toward Th1 predominance in MRL/lpr mice through inhibition of IL-12 production and ameliorated autoimmune disorders. (C) 2001 Elsevier Science B.V. All rights: reserved.
引用
收藏
页码:551 / 559
页数:9
相关论文
共 19 条
[1]  
ADAMSON TC, 1983, J IMMUNOL, V130, P203
[2]   SPONTANEOUS MURINE LUPUS-LIKE SYNDROMES - CLINICAL AND IMMUNOPATHOLOGICAL MANIFESTATIONS IN SEVERAL STRAINS [J].
ANDREWS, BS ;
EISENBERG, RA ;
THEOFILOPOULOS, AN ;
IZUI, S ;
WILSON, CB ;
MCCONAHEY, PJ ;
MURPHY, ED ;
ROTHS, JB ;
DIXON, FJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (05) :1198-1215
[3]   Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice [J].
Balomenos, D ;
Rumold, R ;
Theofilopoulos, AN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :364-371
[4]   CO-STIMULATION VIA CD28 INDUCES ACTIVATION OF A REFRACTORY SUBSET OF MRL-LPR/LPR T-LYMPHOCYTES [J].
CLEMENTS, JL ;
WINSLOW, G ;
DONAHUE, C ;
COOPER, SM ;
ALLISON, JP ;
BUDD, RC .
INTERNATIONAL IMMUNOLOGY, 1993, 5 (11) :1451-1460
[5]   EFFECTS OF TRADITIONAL CHINESE MEDICINES (DAI-SAIKO-TO, SHO-SAIKO-TO AND HACHIMI-ZIO-GAN) ON SPONTANEOUSLY DIABETIC RAT (WBN KOB) WITH EXPERIMENTALLY INDUCED LIPID AND MINERAL DISORDERS [J].
GOTO, M ;
HAYASHI, M ;
TODOROKI, T ;
SEYAMA, Y ;
YAMASHITA, S .
FOLIA PHARMACOLOGICA JAPONICA, 1992, 100 (04) :353-358
[6]  
HAYASHI Y, 1988, AM J PATHOL, V132, P173
[7]   Preventive effects of traditional Chinese (Kampo) medicines on experimental osteoporosis induced by ovariectomy in rats [J].
Hidaka, S ;
Okamoto, Y ;
Nakajima, K ;
Suekawa, M ;
Liu, SY .
CALCIFIED TISSUE INTERNATIONAL, 1997, 61 (03) :239-246
[8]   The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice [J].
Huang, FP ;
Feng, GJ ;
Lindop, G ;
Stott, D ;
Liew, FY .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1447-1459
[9]  
Inagaki H., 1998, Journal of Traditional Medicines, V15, P189
[10]   ANTI-CD4 MONOCLONAL-ANTIBODY THERAPY SUPPRESSES AUTOIMMUNE-DISEASE IN MRL/MP-LPR/LPR MICE [J].
JABS, DA ;
BUREK, CL ;
HU, Q ;
KUPPERS, RC ;
LEE, B ;
PRENDERGAST, RA .
CELLULAR IMMUNOLOGY, 1992, 141 (02) :496-507